To access this element change to forms mode OFF
Grant Award View - GA187350
Engineered human stem cells for mutation-specific eradication of...
GA ID:
GA187350
Agency:
Department of Health and Aged Care
Approval Date:
11-Jun-2021
Publish Date:
30-Aug-2021
Category:
Health and Medical Research
Grant Term:
11-Jun-2021 to 31-May-2024
Value (AUD):
$938,601.95
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 20/21 1.1 Health Policy Research and Analysis
Grant Program:
2020_MRFF_Stem_Cell_Therapies_Mission
Grant Activity:
Engineered human stem cells for mutation-specific eradication of myelofibrosis
Purpose:
Myelofibrosis is a poorly understood cancer of bone marrow that eventually evolves into leukaemia. We have developed new tools by engineering stem cells to mimic driver genes in myelofibrosis that can be used to test novel treatments and help us to understand how and why this disease occurs. Our technology has already led to a mutation specific lead biological and a drug class strategy that we will test as a pre-clinical data package for phase I trials in Australia.
GO ID:
GO Title:
MRFF – Stem Cell Therapies Mission – 2020 Stem Cell Therapies Grant Opportunity
Internal Reference ID:
MRF2008972
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Adelaide
Recipient ABN:
61 249 878 937
Grant Recipient Location
Suburb:
Adelaide
Town/City:
Adelaide
Postcode:
5000
State/Territory:
SA
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC, SA, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, AUSTRIA